Logo image of NTRB

NUTRIBAND INC (NTRB) Stock Price, Quote, News and Overview

NASDAQ:NTRB - Nasdaq - US67092M2089 - Common Stock - Currency: USD

7.46  +0.08 (+1.08%)

After market: 7.49 +0.03 (+0.4%)

NTRB Quote, Performance and Key Statistics

NUTRIBAND INC

NASDAQ:NTRB (2/21/2025, 8:00:01 PM)

After market: 7.49 +0.03 (+0.4%)

7.46

+0.08 (+1.08%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High11.78
52 Week Low2.22
Market Cap82.88M
Shares11.11M
Float3.30M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)04-28 2025-04-28/amc
IPO06-20 2017-06-20


NTRB short term performance overview.The bars show the price performance of NTRB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40

NTRB long term performance overview.The bars show the price performance of NTRB in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of NTRB is 7.46 USD. In the past month the price decreased by -24.65%. In the past year, price increased by 210.83%.

NUTRIBAND INC / NTRB Daily stock chart

NTRB Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.21 829.40B
NVO NOVO-NORDISK A/S-SPONS ADR 27.44 390.99B
JNJ JOHNSON & JOHNSON 16.25 390.76B
AZN ASTRAZENECA PLC-SPONS ADR 20.56 230.17B
MRK MERCK & CO. INC. 11.71 226.40B
NVS NOVARTIS AG-SPONSORED ADR 13.77 215.98B
PFE PFIZER INC 8.46 149.04B
SNY SANOFI-ADR 13.58 136.54B
BMY BRISTOL-MYERS SQUIBB CO 48.97 113.23B
GSK GSK PLC-SPON ADR 7.78 74.77B
ZTS ZOETIS INC 27.1 72.39B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.95 44.58B

About NTRB

Company Profile

NTRB logo image Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. The company is headquartered in Orlando, Florida. The company went IPO on 2017-06-20. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. The company is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Company Info

NUTRIBAND INC

121 S Orange Ave Ste 1500

Orlando FLORIDA US

CEO: Gareth Sheridan

Employees: 13

Company Website: https://nutriband.com/

Investor Relations: http://www.nutriband.com/investors

Phone: 14073776695

NUTRIBAND INC / NTRB FAQ

What is the stock price of NUTRIBAND INC today?

The current stock price of NTRB is 7.46 USD. The price increased by 1.08% in the last trading session.


What is the ticker symbol for NUTRIBAND INC stock?

The exchange symbol of NUTRIBAND INC is NTRB and it is listed on the Nasdaq exchange.


On which exchange is NTRB stock listed?

NTRB stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for NUTRIBAND INC stock?

7 analysts have analysed NTRB and the average price target is 13.26 USD. This implies a price increase of 77.75% is expected in the next year compared to the current price of 7.46. Check the NUTRIBAND INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NUTRIBAND INC worth?

NUTRIBAND INC (NTRB) has a market capitalization of 82.88M USD. This makes NTRB a Micro Cap stock.


How many employees does NUTRIBAND INC have?

NUTRIBAND INC (NTRB) currently has 13 employees.


What are the support and resistance levels for NUTRIBAND INC (NTRB) stock?

NUTRIBAND INC (NTRB) has a support level at 7.25. Check the full technical report for a detailed analysis of NTRB support and resistance levels.


Is NUTRIBAND INC (NTRB) expected to grow?

The Revenue of NUTRIBAND INC (NTRB) is expected to decline by -32.1% in the next year. Check the estimates tab for more information on the NTRB EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NUTRIBAND INC (NTRB) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NUTRIBAND INC (NTRB) stock pay dividends?

NTRB does not pay a dividend.


When does NUTRIBAND INC (NTRB) report earnings?

NUTRIBAND INC (NTRB) will report earnings on 2025-04-28, after the market close.


What is the Price/Earnings (PE) ratio of NUTRIBAND INC (NTRB)?

NUTRIBAND INC (NTRB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.71).


What is the Short Interest ratio of NUTRIBAND INC (NTRB) stock?

The outstanding short interest for NUTRIBAND INC (NTRB) is 7.94% of its float. Check the ownership tab for more information on the NTRB short interest.


NTRB Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to NTRB. When comparing the yearly performance of all stocks, NTRB is one of the better performing stocks in the market, outperforming 98.28% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NTRB Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NTRB. While NTRB seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NTRB Financial Highlights

Over the last trailing twelve months NTRB reported a non-GAAP Earnings per Share(EPS) of -0.71. The EPS decreased by -6.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -54.59%
ROE -60.96%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%44.21%
Sales Q2Q%50.19%
EPS 1Y (TTM)-6.01%
Revenue 1Y (TTM)-3.18%

NTRB Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to NTRB. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -160.87% and a revenue growth -32.1% for NTRB


Ownership
Inst Owners2.21%
Ins Owners54.01%
Short Float %7.94%
Short Ratio1.05
Analysts
Analysts82.86
Price Target13.26 (77.75%)
EPS Next Y-160.87%
Revenue Next Year-32.1%